Back
Aldeyra Therapeutics Vs. United Therapeutics Industry Stock Comparison
Buy
56
ALDX
Aldeyra Therapeutics
Last Price:
4.16
Seasonality Move:
7.79%
Buy
59
UTHR
United Therapeutics
Last Price:
262.33
Seasonality Move:
9.36%
Buy
56
Aldeyra Therapeutics (ALDX)
is a Buy
Is Aldeyra Therapeutics a Buy, Sell or Hold?
- The current Aldeyra Therapeutics [ALDX] share price is $4.16. The Score for ALDX is 56, which is 12% above its historic median score of 50, and infers lower risk than normal.
- ALDX is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
59
United Therapeutics (UTHR)
is a Buy
Is United Therapeutics a Buy, Sell or Hold?
- The current United Therapeutics [UTHR] share price is $262.40. The Score for UTHR is 59, which is 18% above its historic median score of 50, and infers lower risk than normal.
- UTHR is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
ALDX Stock Price Chart
What is Aldeyra Therapeutics's stock price today?
-
The Aldeyra Therapeutics share price today is $4.16
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ALDX is experiencing slight selling pressure.
UTHR Stock Price Chart
What is United Therapeutics's stock price today?
-
The United Therapeutics share price today is $262.40
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and UTHR is experiencing buying pressure, which is a positive indicator for future bullish movement.
ALDX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.11 | Buy |
| Relative Strength Index (14 RSI): | 57.92 | Buy |
| Chaikin Money Flow: | -66892 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (3.78 - 4.4) | Buy |
| Bollinger Bands (100): | (3.02 - 3.96) | Buy |
UTHR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 4.78 | Buy |
| Relative Strength Index (14 RSI): | 72.12 | Buy |
| Chaikin Money Flow: | 636660 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (229.32 - 245.8) | Buy |
| Bollinger Bands (100): | (217.6 - 241.94) | Buy |
ALDX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 4.05 | Buy |
| 20-day SMA: | 4.09 | Buy |
| 50-day SMA: | 3.71 | Buy |
| 200-day SMA: | 4.35 | Sell |
| 8-day EMA: | 4.08 | Buy |
| 20-day EMA: | 3.99 | Buy |
| 50-day EMA: | 3.78 | Buy |
| 200-day EMA: | 4.4 | Sell |
UTHR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 244.44 | Buy |
| 20-day SMA: | 239.17 | Buy |
| 50-day SMA: | 236.82 | Buy |
| 200-day SMA: | 230.08 | Buy |
| 8-day EMA: | 248.11 | Buy |
| 20-day EMA: | 241.53 | Buy |
| 50-day EMA: | 236.21 | Buy |
| 200-day EMA: | 230.75 | Buy |
Aldeyra Therapeutics Earnings Growth & ALDX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.10 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.35 per share, and a decrease next year of $0.02 per share.
United Therapeutics Earnings Growth & UTHR Earnings Dates
- Analysts estimate an earnings increase this quarter of $1.46 per share, a decrease next quarter of $0.00 per share, an increase this year of $5.75 per share, and an increase next year of $1.12 per share.
Aldeyra Therapeutics Technical Analysis
| Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | May 3 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 22 | 23 | 24 | 25 | 26 | 29 | 30 | 01 | 02 | 03 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
United Therapeutics Technical Analysis
| Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | May 3 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 22 | 23 | 24 | 25 | 26 | 29 | 30 | 01 | 02 | 03 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||